Taux de survie à 1 an, 2 ans et 5 ans sur la période 2000-2016, par groupe diagnostique - RNCE

Registre National des Cancers de l’Enfant

Overall survival rates (OS) of childhood cancer in mainland France over 2000-2016, by diagnostic groups and sub.

             
               
 

Taux de survie (IC95%)

Diagnostic groups and subgroups

N

1y-OS

2y-OS

5y-OS

I. Leukemias, myeloproliferative diseases, and myelodysplastic diseases

8503

94.1

[93.6-94.6]

90.4

[89.7-91.0]

86.1

[85.3-86.8]

I.a Lymphoid leukemias

6678

96.4

[95.9-96.8]

93.8

[93.1-94.3]

90.0

[89.3-90.7]

I.b Acute myeloid leukemias

1231

84.6

[82.5-86.5]

76.6

[74.1-78.9]

70.2

[67.5-72.7]

II. Lymphomas and reticuloendothelial neoplasms

3258

96.9

[96.3-97.5]

95.4

[94.6-96.1]

94.3

[93.4-95.1]

II.a Hodgkin lymphomas

1480

99.6

[99.1-99.8]

98.8

[98.0-99.2]

97.7

[96.8-98.4]

II.b Non-Hodgkin lymphomas (except Burkitt lymphomas)

983

94.6

[93.0-95.9]

91.4

[89.4-93.0]

89.5

[87.4-91.3]

II.c Burkitt lymphomas

788

94.9

[93.1-96.3]

94.3

[92.4-95.7]

94.0

[92.0-95.4]

III. CNS and miscellaneous intracranial and intraspinal neoplasms

7500

85.7

[84.9-86.5]

79.3

[78.4-80.2]

74.4

[73.4-75.4]

III.a Ependymomas and choroid plexus tumors

709

91.4

[89.0-93.2]

85.9

[83.1-88.2]

74.6

[71.1-77.8]

III.b Astrocytomas

2798

92.7

[91.7-93.6]

88.8

[87.6-89.9]

87.0

[85.6-88.2]

III.c Intracranial and intraspinal embryonal tumors

1422

75.4

[73.1-77.6]

66.0

[63.4-68.4]

55.7

[53.0-58.4]

III.d Other gliomas

1017

62.3

[59.2-65.2]

44.8

[41.7-47.8]

38.7

[35.6-41.7]

III.e Other specified intracranial and intraspinal neoplasms

1436

97.7

[96.8-98.4]

96.5

[95.4-97.4]

95.3

[94.1-96.3]

IV. Neuroblastomas and other peripheral nervous cell tumors

2404

92.0

[90.8-93.0]

85.6

[84.1-86.9]

76.4

[74.6-78.1]

IV.a Neuroblastomas and ganglioneuroblastomas

2372

92.0

[90.8-93.0]

85.5

[84.0-86.9]

76.2

[74.4-77.9]

V. Retinoblastomas

849

99.5

[98.7-99.8]

99.5

[98.7-99.8]

99.3

[98.4-99.7]

VI. Renal tumors

1637

96.8

[95.8-97.6]

94.5

[93.3-95.5]

92.7

[91.3-93.9]

VI.a Nephroblastomas and other nonepithelial renal tumors

1583

97.0

[96.0-97.7]

94.8

[93.6-95.8]

93.0

[91.6-94.2]

VII. Hepatic tumors

304

90.4

[86.5-93.3]

86.5

[82.1-89.8]

83.1

[78.4-87.0]

VII.a Hepatoblastomas

256

91.0

[86.8-93.9]

86.3

[81.4-90.0]

85.4

[80.5-89.2]

VIII. Malignant bone tumors

1422

94.4

[93.1-95.5]

87.0

[85.1-88.6]

74.1

[71.7-76.4]

VIII.a Osteosarcomas

660

93.0

[90.8-94.7]

85.7

[82.7-88.1]

71.3

[67.5-74.7]

VIII.c Ewing tumors and related bone sarcomas

657

95.9

[94.1-97.2]

87.9

[85.2-90.2]

75.4

[71.8-78.7]

IX. Soft tissue and other extraosseous sarcomas

1882

90.2

[88.7-91.4]

81.8

[80.0-83.5]

72.5

[70.4-74.6]

IX.a Rhabdomyosarcomas

1019

92.5

[90.7-94.0]

83.5

[81.0-85.6]

73.0

[70.1-75.7]

IX.b Fibrosarcomas, peripheral nerve sheath tumors, and other fibrous neoplasms

139

92.8

[87.0-96.1]

87.1

[80.2-91.6]

81.2

[73.3-86.9]

IX.d Other specified soft tissue sarcomas

579

86.2

[83.1-88.7]

79.4

[75.9-82.5]

70.9

[66.9-74.5]

IX.e Unspecified soft tissue sarcomas

141

86.5

[79.7-91.2]

74.4

[66.4-80.8]

66.8

[58.1-74.1]

X. Germ-cell tumors, trophoblastic tumors, and neoplasms of gonads

1113

96.5

[95.2-97.4]

95.0

[93.5-96.1]

94.1

[92.5-95.3]

X.a Intracranial and intraspinal germ cell tumors

423

96.6

[94.4-98.0]

95.1

[92.6-96.8]

94.3

[91.6-96.2]

X.b Malignant extracranial and extragonadal germ cell tumors

291

93.5

[90.0-95.8]

92.1

[88.3-94.7]

90.9

[86.9-93.7]

X.c Malignant gonadal germ cell tumors

369

98.9

[97.1-99.6]

98.3

[96.4-99.3]

97.8

[95.6-98.9]

XI. Other malignant epithelial neoplasms and malignant melanomas

1024

96.5

[95.1-97.5]

95.0

[93.4-96.2]

93.3

[91.5-94.7]

XI.b Thyroid carcinomas

411

99.3

[97.7-99.8]

99.3

[97.7-99.8]

99.0

[97.3-99.6]

XI.d Malignant melanomas

186

92.3

[87.4-95.4]

91.2

[86.0-94.5]

87.4

[81.5-91.5]

XII. Other and unspecified malignant neoplasms

70

86.6

[75.8-92.8]

80.5

[68.9-88.2]

78.9

[67.0-86.9]

All cancers (excluding Langherhans cell histiocytosis)

29966

92.3

[92.0-92.6]

87.8

[87.4-88.2]

83.1

[82.6-83.5]

Langherhans cell histiocytosis

118

93.9

[87.7-97.1]

93.1

[86.6-96.5]

93.1

[86.6-96.5]

All cancers (including Langherhans cell histiocytosis)

30084

92.3

[92.0-92.6]

87.8

[87.4-88.2]

83.1

[82.7-83.5]

               
               
               

Villejuif

INSERM
UMRS1153 Equipe 7
Bâtiment 15/16
16 avenue Paul Vaillant Couturier
94807 Villejuif Cedex

+33 (0)1 45 59 50 37
rnhe@inserm.fr

Nancy

Faculté de Médecine
BP 20199
9 avenue de la Forêt de Haye
54505 Vandoeuvre les Nancy Cedex

+33 (0)3 72 74 63 26
rntse@inserm.fr